Clinical Trial Update: Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, PK of esomeprazole with rifampin and a QT study for alisertib in solid tumors and lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• Alisertib (alisertib)
• Esomeprazole (Esomeprazole)
• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Solid Tumors, Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2019-03-25